AA

Ajit Agrawal

Active Director Director DIN 00333853
DIN 00333853 First appointment Mar 2003 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 10 active board seats
Past companies 5 historical roles
Total affiliations 15 Since Mar 2003
Shareholding value β€’β€’β€’β€’ Premium profile
Directorship timeline
First appointment 06 Mar 2003
Active appointments 11
Total timeline records 15

Ajit Agrawal (DIN 00333853) has 15 recorded board appointments in Indian companies, the first from March 2003, of which 11 are current. The chart and the list below show each company, the role held and the years of the appointment, as filed with the Ministry of Corporate Affairs.

Appointment history

Since 2003
Mgfn Strat Llp Partner · 2025 – present
Current
Kohinoor Medicare Private Limited Director · 2025 – present
Current
Netgro Farms Private Limited Additional Director · 2023 – present
Current
Mla Ventures Private Limited Additional Director · 2023 – present
Current
Bio-Caps Healthcare Limited Additional Director · 2022 – present
Current
V3 International Limited Additional Director · 2022 – present
Current
V3 Biotechnologies Private Limited Additional Director · 2022 – present
Current
Manju Estates Private Limited Additional Director · 2022 – present
Current
Vaishno Enclaves Private Limited Director · 2003 – present
Current
Bio-Caps India Limited Director · 2003 – present
Current
Bio-Caps India Limited Director · 2003 – present
Current
Nipl Infra Projects Private Limited Director · 2011 – 2012
Previous
Axis Infrastructure Private Limited Director · 2006 – 2007
Previous
Previous
Transtel Infrastructure Limited Director · 2005 – 2007
Previous

Interactive timeline

Hover bars for tenure details
Loading chart...
Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available